Improvement in exercise capacity and exercise blood pressure response after transcoronary alcohol ablation therapy of septal hypertrophy in hypertrophic cardiomyopathy

Jae Joong Kim, Cheol Whan Lee, Seong Wook Park, Myeongki Hong, Hee Young Lim, Jae Kwan Song, Young Soo Jin, Seung Jung Park

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Transcoronary alcohol ablation (TAA) therapy of septal hypertrophy was recently proposed as a therapeutic modality for obstructive hypertrophic cardiomyopathy (HC). However, questions remain about the effect of TAA on exercise performance. We performed a time-course analysis of exercise capacity and exercise hemodynamics in 20 patients with symptomatic obstructive HC after TAA. Symptom-limited bicycle exercise testing was performed before and 3 and 12 months after TAA, and cardiac catheterization at 3-month follow-up. The pressure gradient of the left ventricular outflow tract immediately decreased from 58 ± 8 to 4 ± 1 mm Hg at rest (p <0.01) and from 143 ± 11 to 30 ± 6 mm Hg after extrasystole (p <0.01), but partially recovered at 3-month follow-up (14 ± 4 and 40 ± 9 mm Hg, respectively). Left ventricular end-diastolic pressure was not changed after TAA. Peak oxygen consumption increased from 19 ± 2 to 23 ± 1 ml/kg/min (p < 0.01) and exercise duration from 573 ± 47 to 742 ± 46 seconds (p <0.01) at 3-month follow-up, but thereafter reached a plateau. Abnormal patterns of exercise blood pressure response were shown in 9 patients but normalized after TAA. Major complications occurred in 4 patients: no reflow to the left anterior descending coronary artery in 2 patients and ventricular tachycardia requiring cardioversion in 2 patients. During the follow-up period, all patients survived with symptomatic improvement in 17 patients. Thus, TAA is a promising therapeutic modality with improvement in exercise capacity and abnormal exercise blood pressure response in obstructive HC. However, potential serious complications should be considered in the application of TAA.

Original languageEnglish
Pages (from-to)1220-1223
Number of pages4
JournalAmerican Journal of Cardiology
Volume83
Issue number8
DOIs
Publication statusPublished - 1999 Apr 15

Fingerprint

Hypertrophic Cardiomyopathy
Hypertrophy
Alcohols
Exercise
Blood Pressure
Therapeutics
Premature Cardiac Complexes
Electric Countershock
Ventricular Tachycardia
Cardiac Catheterization
Oxygen Consumption
Coronary Vessels
Hemodynamics
Pressure

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Kim, Jae Joong ; Lee, Cheol Whan ; Park, Seong Wook ; Hong, Myeongki ; Lim, Hee Young ; Song, Jae Kwan ; Jin, Young Soo ; Park, Seung Jung. / Improvement in exercise capacity and exercise blood pressure response after transcoronary alcohol ablation therapy of septal hypertrophy in hypertrophic cardiomyopathy. In: American Journal of Cardiology. 1999 ; Vol. 83, No. 8. pp. 1220-1223.
@article{8261291c77694a988b86b4bb02958644,
title = "Improvement in exercise capacity and exercise blood pressure response after transcoronary alcohol ablation therapy of septal hypertrophy in hypertrophic cardiomyopathy",
abstract = "Transcoronary alcohol ablation (TAA) therapy of septal hypertrophy was recently proposed as a therapeutic modality for obstructive hypertrophic cardiomyopathy (HC). However, questions remain about the effect of TAA on exercise performance. We performed a time-course analysis of exercise capacity and exercise hemodynamics in 20 patients with symptomatic obstructive HC after TAA. Symptom-limited bicycle exercise testing was performed before and 3 and 12 months after TAA, and cardiac catheterization at 3-month follow-up. The pressure gradient of the left ventricular outflow tract immediately decreased from 58 ± 8 to 4 ± 1 mm Hg at rest (p <0.01) and from 143 ± 11 to 30 ± 6 mm Hg after extrasystole (p <0.01), but partially recovered at 3-month follow-up (14 ± 4 and 40 ± 9 mm Hg, respectively). Left ventricular end-diastolic pressure was not changed after TAA. Peak oxygen consumption increased from 19 ± 2 to 23 ± 1 ml/kg/min (p < 0.01) and exercise duration from 573 ± 47 to 742 ± 46 seconds (p <0.01) at 3-month follow-up, but thereafter reached a plateau. Abnormal patterns of exercise blood pressure response were shown in 9 patients but normalized after TAA. Major complications occurred in 4 patients: no reflow to the left anterior descending coronary artery in 2 patients and ventricular tachycardia requiring cardioversion in 2 patients. During the follow-up period, all patients survived with symptomatic improvement in 17 patients. Thus, TAA is a promising therapeutic modality with improvement in exercise capacity and abnormal exercise blood pressure response in obstructive HC. However, potential serious complications should be considered in the application of TAA.",
author = "Kim, {Jae Joong} and Lee, {Cheol Whan} and Park, {Seong Wook} and Myeongki Hong and Lim, {Hee Young} and Song, {Jae Kwan} and Jin, {Young Soo} and Park, {Seung Jung}",
year = "1999",
month = "4",
day = "15",
doi = "10.1016/S0002-9149(99)00063-6",
language = "English",
volume = "83",
pages = "1220--1223",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "8",

}

Improvement in exercise capacity and exercise blood pressure response after transcoronary alcohol ablation therapy of septal hypertrophy in hypertrophic cardiomyopathy. / Kim, Jae Joong; Lee, Cheol Whan; Park, Seong Wook; Hong, Myeongki; Lim, Hee Young; Song, Jae Kwan; Jin, Young Soo; Park, Seung Jung.

In: American Journal of Cardiology, Vol. 83, No. 8, 15.04.1999, p. 1220-1223.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Improvement in exercise capacity and exercise blood pressure response after transcoronary alcohol ablation therapy of septal hypertrophy in hypertrophic cardiomyopathy

AU - Kim, Jae Joong

AU - Lee, Cheol Whan

AU - Park, Seong Wook

AU - Hong, Myeongki

AU - Lim, Hee Young

AU - Song, Jae Kwan

AU - Jin, Young Soo

AU - Park, Seung Jung

PY - 1999/4/15

Y1 - 1999/4/15

N2 - Transcoronary alcohol ablation (TAA) therapy of septal hypertrophy was recently proposed as a therapeutic modality for obstructive hypertrophic cardiomyopathy (HC). However, questions remain about the effect of TAA on exercise performance. We performed a time-course analysis of exercise capacity and exercise hemodynamics in 20 patients with symptomatic obstructive HC after TAA. Symptom-limited bicycle exercise testing was performed before and 3 and 12 months after TAA, and cardiac catheterization at 3-month follow-up. The pressure gradient of the left ventricular outflow tract immediately decreased from 58 ± 8 to 4 ± 1 mm Hg at rest (p <0.01) and from 143 ± 11 to 30 ± 6 mm Hg after extrasystole (p <0.01), but partially recovered at 3-month follow-up (14 ± 4 and 40 ± 9 mm Hg, respectively). Left ventricular end-diastolic pressure was not changed after TAA. Peak oxygen consumption increased from 19 ± 2 to 23 ± 1 ml/kg/min (p < 0.01) and exercise duration from 573 ± 47 to 742 ± 46 seconds (p <0.01) at 3-month follow-up, but thereafter reached a plateau. Abnormal patterns of exercise blood pressure response were shown in 9 patients but normalized after TAA. Major complications occurred in 4 patients: no reflow to the left anterior descending coronary artery in 2 patients and ventricular tachycardia requiring cardioversion in 2 patients. During the follow-up period, all patients survived with symptomatic improvement in 17 patients. Thus, TAA is a promising therapeutic modality with improvement in exercise capacity and abnormal exercise blood pressure response in obstructive HC. However, potential serious complications should be considered in the application of TAA.

AB - Transcoronary alcohol ablation (TAA) therapy of septal hypertrophy was recently proposed as a therapeutic modality for obstructive hypertrophic cardiomyopathy (HC). However, questions remain about the effect of TAA on exercise performance. We performed a time-course analysis of exercise capacity and exercise hemodynamics in 20 patients with symptomatic obstructive HC after TAA. Symptom-limited bicycle exercise testing was performed before and 3 and 12 months after TAA, and cardiac catheterization at 3-month follow-up. The pressure gradient of the left ventricular outflow tract immediately decreased from 58 ± 8 to 4 ± 1 mm Hg at rest (p <0.01) and from 143 ± 11 to 30 ± 6 mm Hg after extrasystole (p <0.01), but partially recovered at 3-month follow-up (14 ± 4 and 40 ± 9 mm Hg, respectively). Left ventricular end-diastolic pressure was not changed after TAA. Peak oxygen consumption increased from 19 ± 2 to 23 ± 1 ml/kg/min (p < 0.01) and exercise duration from 573 ± 47 to 742 ± 46 seconds (p <0.01) at 3-month follow-up, but thereafter reached a plateau. Abnormal patterns of exercise blood pressure response were shown in 9 patients but normalized after TAA. Major complications occurred in 4 patients: no reflow to the left anterior descending coronary artery in 2 patients and ventricular tachycardia requiring cardioversion in 2 patients. During the follow-up period, all patients survived with symptomatic improvement in 17 patients. Thus, TAA is a promising therapeutic modality with improvement in exercise capacity and abnormal exercise blood pressure response in obstructive HC. However, potential serious complications should be considered in the application of TAA.

UR - http://www.scopus.com/inward/record.url?scp=0345003773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345003773&partnerID=8YFLogxK

U2 - 10.1016/S0002-9149(99)00063-6

DO - 10.1016/S0002-9149(99)00063-6

M3 - Article

VL - 83

SP - 1220

EP - 1223

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 8

ER -